S-ICD Electrode Registry

Status Not yet recruiting

Clinical Trial Summary

The subcutaneous implantable cardioverter defibrillator (S-ICD) is established in the prevention of sudden cardiac death, but recently a defect of the electrode's Sense-B component was reported in some patients. This lead to inadequate shocks due to noise. The cause and incidence of this defect are unknown. The manufacturer issued a warning regarding this defect and a possible premature depletion of the battery in some device. Independent data on the incidence of these issues is limited. Further data is needed to better understand the risk of these complications.

Clinical Trial Description

The S-ICD therapy is an established treatment for primary and secondary prevention of sudden cardiac death. Recently, a report was published about a previously described complication of the electrode, in which a defect of the so-called Sense-B component is reported in a few affected patients. The defect of this component of the electrode leads to electrode noise and subsequent inadequate shocks. The cause of the defect and the incidence are currently unknown. The manufacturer Boston Scientific has issued a warning and advisory. In addition to this advisory regarding the electrode of the S-ICD, there is also an active warning from the manufacturer regarding the possible premature exhaustion of the S-ICD battery. This is caused by an error in the manufacturing process of approximately 40,000 devices produced in 2018. The manufacturer estimates the incidence of premature battery exhaustion to be 4-15% within 5 years. Independent data on the incidence of premature exhaustion of these devices were initially scarce. The investigators conducted a retrospective data query in 2021 to capture the incidence of battery exhaustion at that time. The incidence was 3.7% after 5 years. The average follow-up time was only 3 years. The incidence of premature exhaustion increased significantly after 3 years, so data with a longer follow-up period is urgently needed. Given that these data already show that the incidence of premature exhaustion increases significantly after 3 years and the observation period in the retrospective data was on average slightly under 3 years, a further query of the existing clinical data on the battery as part of this register is also planned. This would allow for a more accurate estimate of the risk of premature battery depletion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05713708
Study type	Observational
Source	Universitätsklinikum Köln
Contact	Jakob Lüker, MD
Phone	+4922147832396
Email	jakob.lueker@uk-koeln.de
Status	Not yet recruiting
Phase
Start date	November 1, 2023
Completion date	November 3, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02923726` - Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP	N/A
Recruiting	`NCT05175937` - REal World Assessment for Patients Implanted With Implantable CardioverTer DefibrIllatOr Using Bluetooth Technology
Completed	`NCT02026102` - A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)	N/A
Completed	`NCT01262508` - Development of Algorithms to Predict Hemodynamic Instability	N/A
Completed	`NCT00998218` - Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction	Phase 3
Completed	`NCT00845286` - Marathon, Genetics, Inflammation and the Cardiovascular System: MAGIC-Trial	N/A
Active, not recruiting	`NCT00562757` - Prospective Study to Identify Patients at Risk of Dangerous Ventricular Arrhythmias	N/A
Completed	`NCT00622453` - Arrhythmias in Myotonic Muscular Dystrophy	N/A
Completed	`NCT03833843` - Sudden Cardiac Death in Systemic Right Ventricle
Completed	`NCT04024865` - Domperidone and Risk of Serious Cardiac Events in Postpartum Women
Recruiting	`NCT05799833` - Low QRS Voltages in Young Healthy Individuals and Athletes
Recruiting	`NCT05694572` - Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices
Not yet recruiting	`NCT03622307` - Subcutaneous ICD Therapy Combined With VT Ablation for the Secondary Prevention of Sudden Cardiac Death	N/A
Recruiting	`NCT02056509` - The Effect of Chest Compression and Ventilation Coordination During Cardiopulmonary Resuscitation.	N/A
Recruiting	`NCT02058771` - Utilising Lifemap to Investigate Malignant Arrhythmia Therapy
Terminated	`NCT01948206` - Study of Paced QRS Duration as a Marker of Sudden Cardiac Death	N/A
Completed	`NCT01227785` - Next Generation INCEPTA Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT-D) Field Following Study	N/A
Completed	`NCT00534300` - Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker	Phase 1/Phase 2
Terminated	`NCT00524862` - Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death	N/A
Recruiting	`NCT00181233` - Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk